Skip to main content
. 2023 Jun 1;13(9):3782–3801. doi: 10.1016/j.apsb.2023.05.034

Figure 8.

Figure 8

Cell-based screening and structural modification of Taspine yields SMU-Y6. (A) SMU-Y6 exhibited less cytotoxicity, higher solubility and better activity in blocking TLR2 in preference to TLR4. It exerts its anti-inflammatory effect through the TLR2/MyD88/NF-κB and MAPK signaling pathway. (B) SMU-Y6 blocked TLR2/MyD88/NF-κB and MAPK signaling pathways to reduce the production of inflammatory cytokines and play an anti-inflammatory role.